OSE Immunotherapeutics SA (EPA:OSE)
3.394
-0.024 (-0.70%)
Jun 23, 2026, 5:35 PM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €79.83 million as of June 23, 2026. Its market cap has decreased by -31.22% in one year.
Market Cap
79.83M
Enterprise Value
93.47M
Revenue
2.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.39
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 79.83M, a decrease of -23.46%. That is a compound annual growth rate of -2.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 79.83M | -30.87% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 205.96M |
| Cellectis | 193.85M |
| Innate Pharma | 150.88M |
| Sensorion | 132.54M |
| Valerio Therapeutics Société anonyme | 103.39M |
| Adocia | 80.81M |
| ABIONYX Pharma | 77.47M |
| MaaT Pharma | 53.80M |